NCT05417386 2025-11-18
FOLFIRINOX + NIS793 in Pancreatic Cancer
Massachusetts General Hospital
Phase 1 Terminated
Massachusetts General Hospital
Dana-Farber Cancer Institute
Universitätsklinikum Hamburg-Eppendorf
NYU Langone Health
M.D. Anderson Cancer Center
CHIR-Net
National Cancer Institute (NCI)